Skip to main content
Premium Trial:

Request an Annual Quote

Shamrock Structures Lands VC Funding to Market Argonne Proteomics Technology

NEW YORK, Nov. 4 (GenomeWeb News) - Shamrock Structures, a Chicago-based structural proteomics startup, has secured an undisclosed amount of funding from early-stage venture capital firm Flavin Ventures, the company said today.

Shamrock Structures will offer services in structural proteomics - such as protein cloning, expression, purification, and crystallization -- via a special arrangement with Argonne National Laboratory that provides access to the Advanced Photon Source synchrotron.   

"Our agreement with Shamrock Structures will allow us to more easily deliver Argonne's powerful structural proteomics technologies to the marketplace," said Andrej Joachimiak, head of the Structural Biology Center at Argonne National Laboratory.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more